Saturday 17 October 2026
Export OGI’s income statement to Excel — free account
Organigram Global Inc.
OGI Healthcare Drug Manufacturers Specialty & Generic
Organigram Global Inc.’s revenue for fiscal 2025 (year ended September 2025) was $185.3 million, up 57.7% from fiscal 2024. In the quarter to June 2026, revenue grew 49.3%, EPS grew 1,966.7% and free cash flow fell 192.3%, each against the same quarter a year earlier.
0.93
0.00
0.00%
Follow OGI
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
4 | 4 | 5 | 5 |
+8 more TTM periods Free account |
| 20.20% | (6.34%) | 5.25% | (7.46%) | ||
| 12.70% | (4.56%) | 3.60% | (5.05%) | ||
ROIC |
(1.53%) | (3.94%) | (1.51%) | (3.61%) | |
Return on Tangible Assets |
29.94% | (8.37%) | 6.35% | (8.79%) | |
Average Days of Receivables |
104.53 | 71.65 | 65.26 | 91.34 | |
Free Cash Flow per Share |
(0.16) | (0.12) | (0.20) | (0.14) | |
Free Cash Flow |
(21.14) | (15.72) | (26.36) | (17.54) | |
Capital Expenditures |
(0.60) | (8.15) | (12.44) | (12.11) | |
| Other line items | |||||
Cash ROIC |
(5.65%) | (5.05%) | (8.50%) | (5.66%) | |
Accounts Receivable Turnover |
4.23 | 5.38 | 5.77 | 5.03 | |
Accounts Payable Turnover |
2.07 | 2.63 | 2.68 | 2.45 | |
Inventory Turnover |
1.35 | 1.43 | 1.52 | 1.62 | |
Average Days of Payables |
185.58 | 152.30 | 144.27 | 192.79 | |
Days of Inventory on Hand |
306.51 | 281.45 | 269.36 | 267.76 | |
Tax Rate |
0.18 | 0.00 | 0.00 | (0.36) | |
Research and Development Expense of Revenue |
3.07% | 3.66% | 3.81% | 4.22% | |
Selling, General and Administrative Expense of Revenue |
35.65% | 37.14% | 36.07% | 36.49% | |
Share Based Compensation of Revenue |
1.17% | 1.28% | 1.31% | 1.63% | |
Operating CF/Net income |
(0.32) | 0.44 | (1.07) | 0.31 | |
Depreciation/Fixed assets |
0.21 | 0.16 | 0.16 | 0.15 | |
Capex/Depreciation |
(0.03) | (0.57) | (0.89) | (0.94) | |
Revenue per Share |
1.65 | 1.51 | 1.49 | 1.45 | |
Operating CF per Share |
(0.15) | (0.06) | (0.10) | (0.04) | |
Capex per Share |
0.00 | (0.06) | (0.09) | (0.09) | |
Capex to Sales |
0.00 | 0.04 | 0.06 | 0.07 |
Columns are period end dates